Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A7, pseudogene (ANKRD20A7P)
- Target
- ANKRD20A7P
- Molecular classification
- Pseudogene, Non-coding RNA (where transcribed; long non-coding RNA pseudogene), Ankyrin repeat domain family member (by sequence homology, but lacking function)
01
Overview
ANKRD20A7P (ankyrin repeat domain 20 family member A7, pseudogene) is a human gene annotated as a pseudogene, meaning it shares sequence homology with other ankyrin repeat domain-containing genes but is inactivated by mutations and does not produce a functional protein. Pseudogenes like ANKRD20A7P arise by duplication, retrotransposition, or processed events and often lack regulatory elements or accumulate mutations that disable protein-coding ability. While some pseudogenes may acquire regulatory functions affecting gene expression or participate as non-coding RNAs, there is no specific evidence for functional or disease association of ANKRD20A7P, nor is it a target for drugs or therapeutic strategies.
- Other names
- ANKRD20A7P
02
Mechanism of action
Not applicable. There are no drugs targeting this pseudogene
03
Biological functions
No direct biological function as a proteinLike other pseudogenes, may participate in regulation of gene expression (e.g., acting as a microRNA sponge or competing endogenous RNA), but there is no direct evidence for this specific pseudogene
04
Disease associations
None documented for ANKRD20A7P specificallyIn general, some pseudogenes can be implicated in gene regulation related to cancer and other diseases, but no disease associations have been reported for ANKRD20A7PNo established or validated role in disease
Beyond the preview
Go deeper on Ankyrin repeat domain 20 family member A7, pseudogene (ANKRD20A7P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A7, pseudogene (ANKRD20A7P).